EVCM Insider Filing: RSU Withholding and 10b5-1 Sale by President
Rhea-AI Filing Summary
Matthew David Feierstein, President of EverCommerce Inc. (EVCM), reported changes in his holdings. On 09/01/2025 the company withheld 2,685 shares to cover tax withholding upon vesting of restricted stock units granted March 1, 2022, leaving 2,236,383 shares beneficially owned directly. On 09/02/2025 he sold 25,000 shares at a weighted average price of $11.2419 per share, reducing his direct holdings to 2,211,383. He also holds 150,000 shares indirectly through a family trust. All sales were made pursuant to a Rule 10b5-1 trading plan dated September 6, 2024. The Form 4 was signed by attorney-in-fact Lisa Storey on 09/03/2025.
Positive
- Transactions executed under a Rule 10b5-1 trading plan, indicating pre-established, compliant selling arrangements
- Clear disclosure of RSU tax-withholding and a weighted-average sale price with an offer to provide per-tranche details upon request
Negative
- None.
Insights
TL;DR: Insider executed routine RSU tax-withholding and a Rule 10b5-1 sale for 25,000 shares, modest relative to total holdings.
The filing shows a standard tax-withholding disposition of vested RSUs and a planned open-market sale under a pre-established 10b5-1 plan. The sale of 25,000 shares against direct holdings of ~2.2 million represents a small percentage reduction, suggesting no unplanned liquidity event. The weighted-average sale price of $11.2419 is provided but without context of recent market prices or realized proceeds per tranche. No derivative transactions were reported.
TL;DR: Disclosure is compliant and transparent; use of a 10b5-1 plan and explanatory footnotes reduces regulatory risk.
The reporter checked the box indicating the transactions were pursuant to a Rule 10b5-1 plan and provided explanatory footnotes describing tax-withholding and the weighted-average sale price range. The filing includes an attorney-in-fact signature, which is acceptable if authority is documented. There are no indications of undisclosed derivative activity or other reportable exceptions in this Form 4. From a compliance perspective, the filing appears complete and aligned with Section 16 reporting norms.